mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.1 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |